BBH

Featured

Why This Biotech ETF Leads the Pack

By Todd ShriberFebruary 21, 2014

Featured

The One ETF Really Benefiting From the Intercept Pharma News

By Todd ShriberJanuary 9, 2014

Equity ETFs

Most Popular Tickers on ETF Trends Week of Dec. 27

By Todd ShriberDecember 28, 2013

Featured

Intense Duel to be 2013’s Best Health Care ETF

By Tom LydonDecember 23, 2013

Equity ETFs

Solar ETFs Look for 2014 Sequel

By Todd ShriberDecember 19, 2013

Featured

5 ETF Outperformers May Still Have Legs

By Max ChenDecember 17, 2013

Featured

The Emergency Room ETF Could Soar Again in 2014

By Tom LydonDecember 17, 2013

Equity ETFs

Some of 2012’s Best Sector ETFs Kept Soaring in 2013

By Tom LydonDecember 10, 2013

Featured

Biotech ETFs: More Tricks Than Treats in October

By Max ChenOctober 31, 2013

Featured

Biotech ETFs Look to Claw Back After Shutdown Slump

By Todd ShriberOctober 22, 2013

Featured

Triple-Digit Divas Reside in These ETFs

By Todd ShriberOctober 18, 2013

Featured

Sell-Off in Biotech ETFs Could Be a Temporary Setback

By Tom LydonOctober 10, 2013

Featured

10 ETF Investments That Got the Most Bang for Your Buck

By Tom LydonOctober 8, 2013

Featured

ETF Categories That Just Keep On Winning

By Gary GordonOctober 2, 2013

Featured

Three ETFs to Play the Outperforming Biotech Sector

By Tom LydonAugust 19, 2013

Featured

Investors Clamor for Generic Drug ETF

By Tom LydonMay 6, 2013

Featured

Ups and Downs for ETFs in 2012

By Tom LydonDecember 31, 2012

Featured

Why Biotech ETFs are a Top Sector in 2012

By Tom LydonDecember 19, 2012